Chimeric switch receptor: switching for improved adoptive T-cell therapy against cancers

« Expansion of gamma delta T cells – a short review on bisphosphonate and K562-based methods Intraperitoneal immunotherapy with T cells stably and transiently expressing anti-EpCAM CAR in xenograft models of peritoneal carcinomatosis »